Anhui Provincial Hospital: Carcinoma, Hepatocellular trials

The registry lists 11 Carcinoma, Hepatocellular studies with Anhui Provincial Hospital as lead sponsor. 6 are open to participants now and 0 have results posted.

Phase 2 4Phase 4 2No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Oral Zinc Supplementation Combined With Targeted Immunotherapy for Unresectable or Advanced Hepatocellular CarcinomaRecruitingNCT07793695Phase 2
• Liver Volume Metrics for Predicting Immunotherapy Prognosis in Unresectable Hepatocellular CarcinomaRecruitingNCT07782632
• The Treatment of Liver Injury After Liver Resection With Polyene PhosphatidylcholineRecruitingNCT07150624Phase 4
• A Single-Arm, Multicenter, Exploratory Clinical Study of Transarterial Chemoembolization (TACE) Combined With Iparomlimab and Tuvonralimab Injection and Bevacizumab Injection for the Treatment of Unresectable, Non-Metastatic Hepatocellular Carcinoma (HCC)Not yet recruitingNCT07128251Phase 2
• Adjuvant Treatment of Patients With High Risk of Recurrent Hepatocellular Carcinoma With Donafenib in Combination With EnvafolimabRecruitingNCT06498622Phase 2
• A Study to Evaluate Tislelizumab Combined With Sitravatinib as Adjuvant Therapy in Participants With HCC at High Risk of Recurrence After Curative ResectionRecruitingNCT05407519Phase 2
• HCC-MPDS Multimodal Deep Learning Prognostic Model for Resectable HCCCompletedNCT07700082
• Estimation and Prediction of Individual Benefit From Postoperative Adjuvant Transcatheter Arterial Chemoembolization For Patients With Hepatocellular CarcinomaCompletedNCT07562763
• Precision Dietary Intervention Improves Postoperative Energy Intake, Nutritional Status, and Recovery in Patients Undergoing Hepatectomy for Liver Cancer: A Randomized Controlled TrialCompletedNCT07349576Not applicable
• "cindilizumab + Bevacizumab + Coenzyme I for Injection" in Unresectable Hepatocellular CarcinomaActive, not recruitingNCT06590844Phase 4
• Clinical Study of MRD Recurrence Monitoring After Surgical Resection of Hepatocellular CarcinomaStatus unknownNCT05458115